Inflazome is developing inhibitors of the inflammasome, a compelling biological target that regulates our innate immune response, now associated with a wide variety of diseases.
Inflammasomes generate signals that cause immune cells to fight infections. Usually this is beneficial, but unwanted inflammation can happen when immune cells become activated without control. We can precisely block inflammasome signals, eliminating a root cause of inflammation.
medtech, cell, biotech

Articles about Inflazome:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Inflazome? We’re happy to assist you with our Startup Sourcing service.